Abbott banks on glucose monitors, new launches to ride out China, currency hit
Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...
The Gazette10d
Abbott banks on glucose monitors, new launches to ride out China, currency hit
The company, which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre ... rose 1.3%, reversing ...
Is There More Upside For ABT Stock After A 10% Jump In A Week?
The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...
Longview News-Journal22d
Chronic Disease Management: Innovations in Therapeutics, Devices, and Global Markets
One advance in chronic disease management is biowearable technology, as exemplified by Abbott's FreeStyle Libre. This device allows real-time tracking of biomarkers, such as glucose levels ...
pharmaphorum5d
Real-time Abbott glucose monitor available to NHS after UK launch
Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...
Complex12d
Nike's Next Doernbecher Freestyle Collection Releases This Weekend
That tradition continues this winter with today's unveiling of the latest Doernbecher Freestyle 20 collection, shown here. The latest range includes special iterations of the Air Jordan 6 ...